Clinical & Policy

18 Million Midlife Women Overdue for Cancer Screenings: JAMA Study Reveals 50% Drop-Off in Routine Care

A landmark investigation in JAMA Network Open finds that over 18 million midlife women in the United States are overdue for at least one routine cancer screening. A steep 50% drop-off in routine breast, cervical, and colorectal testing occurs as patients transition beyond their childbearing years, emphasizing the urgent need for accessible lifespan well-woman care.

August 28, 20266 min readStaff Writer

Based on reporting from JAMA Network Open / Contemporary OB/GYN: Over 18 Million Midlife Women Overdue for Cancer Screenings.

Certified Nurse-Midwife holding a supportive preventive health consultation with a midlife patient

The JAMA Network Open Findings: An 18-Million Patient Gap

A large-scale cross-sectional study published in JAMA Network Open evaluated preventive health examination patterns among civilian women aged 45 to 64 across the United States. The researchers discovered a sobering clinical reality: more than 18 million midlife women are currently overdue for at least one life-saving cancer screening.

The investigation assessed adherence across three foundational screening modalities: screening mammography for breast cancer, cervical cytology and high-risk human papillomavirus (hrHPV) co-testing for cervical cancer, and colonoscopy or stool-based testing for colorectal cancer.

Most striking was the steep 50% drop-off in preventive healthcare engagement that manifests during perimenopause and midlife. While patients frequently maintain consistent healthcare contact throughout pregnancy and early family planning, clinical engagement plummets once childbearing is completed.

Why Midlife Preventive Care Drops Precipitously

Clinicians frequently refer to this phenomenon as the 'obstetric cliff.' During childbearing years, individuals attend regular obstetrical and contraceptive visits. However, when contraception needs stabilize or surgical sterilization occurs, many individuals mistakenly assume they no longer require annual well-woman examinations.

Competing sociological factors intensify this screening deficit. Midlife women disproportionately carry 'sandwich generation' responsibilities, balancing full-time careers while caring for aging parents and supporting growing children. In the face of intense domestic and professional demands, personal healthcare is frequently deprioritized.

Furthermore, previous negative healthcare encounters play a significant role. Many women report rushed 10-minute office visits where their perimenopausal concerns (such as vasomotor hot flashes, sleep disturbances, or pelvic floor discomfort) were dismissed as inevitable aging. Facing cold exam rooms and hurried procedures, millions of individuals opt to forgo preventive care entirely.

The Core Midlife Preventive Screening Triad

The three primary cancer screenings assessed in the study have clear clinical parameters that every individual in midlife should review:

1. Breast Cancer Screening: The U.S. Preventive Services Task Force (USPSTF) and the American College of Obstetricians and Gynecologists (ACOG) recommend biennial or annual screening mammography starting at age 40 for average-risk individuals, continuing through at least age 74. Patients with dense breast tissue or a significant family history benefit from supplemental ultrasound or MRI surveillance.

2. Cervical Cancer Screening: Current guidelines advise high-risk HPV testing alone, or co-testing with cervical cytology (Pap smear), every 5 years for individuals aged 30 to 65 with normal prior results. Regular screening detects high-grade precancerous lesions years before malignant transformation occurs.

3. Colorectal Cancer Screening: Routine screening now begins at age 45 for all average-risk adults. Patients can select between visual examinations (colonoscopy every 10 years) or non-invasive stool-based assessments (annual fecal immunochemical test [FIT] or stool DNA-FIT co-testing every 3 years).

Certified Nurse-Midwives as Lifespan Well-Woman Clinicians

A common misconception is that Certified Nurse-Midwives only provide pregnancy and delivery care. In reality, CNMs are fully trained and nationally board-certified to deliver comprehensive gynecological and primary wellness care throughout a patient's entire lifespan, from adolescence through menopause and post-menopause.

Midwife-led annual exams represent a stark contrast to rushed conventional appointments. With dedicated visit times often ranging from 30 to 45 minutes, midwives create space for trauma-informed care. Midwives explain every step of physical exams, obtain explicit consent before touching, and utilize techniques that maximize physical comfort.

In Arizona, CNMs perform clinical breast examinations, collect cervical screening specimens, order screening mammograms and diagnostic breast imaging, order colorectal screening kits, and manage perimenopausal hormone therapy. They also evaluate cardiovascular risk profiles, lipid panels, bone mineral density, and thyroid function.

Re-Establishing Routine Care Without Stigma

Healthcare teams emphasize that individuals who have missed screenings for five, ten, or more years should feel welcomed back into clinical care without reprimand. The purpose of a preventive visit is forward-looking health optimization, not retrospective judgment.

Hospital-affiliated midwifery practices throughout Phoenix, Chandler, Gilbert, and Peoria offer an accessible, compassionate entry point for midlife patients seeking to re-establish care. A single collaborative visit can re-establish mammography schedules, update cervical health records, order colorectal screening tests, and address persistent perimenopausal symptoms.

By closing the 18-million woman screening gap, primary and midwifery care providers have the clinical opportunity to detect precancerous cellular changes early, dramatically improving long-term survivorship and quality of life.

Questions this headline raises

Midlife women (ages 40 to 65) should receive regular screening mammograms for breast cancer (starting at age 40), high-risk HPV testing or Pap co-testing for cervical cancer every 5 years (through age 65), and colorectal cancer screening (starting at age 45 via colonoscopy or stool-based testing).

Ctrl+K